课题基金 / 基金详情

BASIC STUDIES ON A TRANSCRIPTION FACTOR NF-κB AND SIGNAL TRANSDUCTION THERAPY

BASIC STUDIES ON A TRANSCRIPTION FACTOR NF-κB AND SIGNAL TRANSDUCTION THERAPY
转录因子NF-κB与信号转导治疗的基础研究
批准号:
10557052
负责人:
OKAMOTO Takashi
金额:
$8.77万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

OKAMOTO Takashi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
NF-κB controls gene expression of a number of genes and is recently found to be involved in suppression of apoptosis. NF-κB exerts its biological actions through interacting with other cellular proteins. In order to identify molecular partners, we have applied the yeast two-hybrid screening with portions of NF-κB p65 subunit (RelA) as "baits". We have isolated a new gene, called RelA-associated inhibitor (RAI), which have subsequently shown to be located in the nucleus and block the NF-κB -mediated gene expression by inhibiting its DNA binding. Thus, RAI appears to act as a fail-safe mechanism to ensure the silencing of NF-κB or as a feed-back system to downregulate NF-κB activity. Using a different portion of p65 as a "bait", we have identified AES and TLE1, that are the members of Groucho family proteins known as transcriptional co-repressors of Drosophila homologue of human RelA, Dorsal. We have demonstrated that human AES/TLE1 also blocks NF-κB -mediated transcription Since NF-κB has recently been found to be involved in the morphogenesis of higher multicellular organisms, it is expected that human Groucho homologue may be involved in the human body plan in association with NF-κB although the exact mechanism and dynamics should further be explored. Finally, we have identified 53BP2, initially identified as an interacting molecular partner of a tumor suppressor p53 protein, as an interacting protein with p65. When 53BP2 is transduced into cells, these cells were killed with the characteristic features suggesting apoptosis such as fragmented and condensed nuclei and annexin V staining. interestingly, when p65 gene is cotransfected with 53BP2, the 53BP2-induced cell death was completely blocked. These findings suggest that interaction of p65 with 53BP2 may explain, at least in a part, how NF-κB and p65 (RelA) blocks apoptosis.
期刊论文(97)
专著(0)
科研奖励(0)
会议论文
Asamitu, K.: "Conservation of the central proline-rich (PxxP) motifs of human immunodeficiencyvirus type 1 Nef protein during the disease progression in two hemophiliac patients"FEBS Lett.. 459. 399-404 (1999)
Asamitu, K.:“在两名血友病患者的疾病进展过程中人类免疫缺陷病毒 1 型 Nef 蛋白的中央富含脯氨酸 (PxxP) 基序的保守”FEBS Lett.. 459. 399-404 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Okamoto, M., Okamoto, T. and Baba, M.: "Inhibition of human immunodeficiency virus type 1 replication by combination of transcription inhibitor K-12 and other antiretroviral agents in acutely and chronically infected cells."Antimicob. Agents. Chemother..
Okamoto, M.、Okamoto, T. 和 Baba, M.:“在急性和慢性感染细胞中结合转录抑制剂 K-12 和其他抗逆转录病毒药物抑制人类免疫缺陷病毒 1 型复制。”Antimicob。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mika Okamoto: "Inhibition of human immunodeficiency virus type lreplication by combination of transcription inhibitor K-12 and other antiretroviral agents in acutely and chronically infected cells." Antimicrob.Agents.Chemother.(in press). (1999)
Mika Okamoto:“在急性和慢性感染的细胞中,通过转录抑制剂 K-12 和其他抗逆转录病毒药物的组合来抑制人类免疫缺陷病毒 I 型复制。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
87
    Revealing evolution of galaxies and galaxy clusters by high-resolution simulations and wide-field, high-resolution observations
    • 批准号:
      19H01931
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.23万
    • 财政年份:
      2019
    • 负责人:
      OKAMOTO Takashi
    • 依托单位:
    Historical Reexamination of Modern East Asia: from the Shelves of the George Morrison Pamphlet Collection
    • 批准号:
      26284108
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.99万
    • 财政年份:
      2014
    • 负责人:
      OKAMOTO Takashi
    • 依托单位:
    Analysis of antitumor effect against human melanoma by using STAT3 inhibitor (human-rR9-GRIM19)
    • 批准号:
      25860941
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.58万
    • 财政年份:
      2013
    • 负责人:
      OKAMOTO Takashi
    • 依托单位:
    Clarification of alteration mechanism of seismic motion reached to landslide area
    国内基金
    海外基金
    利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
    • 批准号:
      82371145
    • 项目类别:
      面上项目
    • 资助金额:
      46.00万元
    • 批准年份:
      2023
    • 负责人:
      陶永
    • 依托单位:
    转录因子BCL6抑制ICOSL表达优化生发中心反应的机制研究
    • 批准号:
      82371745
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      张文倩
    • 依托单位:
    转录因子LEF1低表达抑制HMGB1致子宫腺肌病患者子宫内膜容受性低下的分子机制
    • 批准号:
      82371704
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      徐步芳
    • 依托单位:
    小鼠肺腺鳞癌转分化类器官模型的建立及表观调控分子机制研究